144 ·Filed Mar 30, 2026
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral
Monitor for actual execution of the sale; while this is a routine Form 144 filing, any large insider transaction could influence short-term sentiment, especially in a small-cap biotech with limited float.
Final — all horizons settled through T+60d ⚠ clustered
RAPP ▲ +28.03% at T+60d
NEUTRAL call ✓ call won +28.03% · α vs SPY +15.65% · entry $31.29 → $40.06
T+1d
+1.21%
call +1.21% · α +0.47%
$31.67
settled 7mo ago
T+5d
+7.67%
call +7.67% · α +3.73%
$33.69
settled 7mo ago
T+20d
+6.41%
call +6.41% · α -3.02%
$33.30
settled 6mo ago
T+60d
+28.03%
call +28.03% · α +15.65%
$40.06
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Cheryl Gault, an officer of Rapport Therapeutics, filed a Form 144 to propose the sale of 10,000 shares worth approximately $278,400. The shares were originally issued as founders' shares on September 5, 2024, and the sale is scheduled for March 30, 2026.
Key Facts
- Cheryl Gault, an officer of Rapport Therapeutics, intends to sell 10,000 shares.
- The proposed sale is valued at $278,400 based on the current market price.
- Shares are being sold under Rule 144 and were originally issued as founders' shares on September 5, 2024.
- The sale is scheduled to occur on March 30, 2026, through Morgan Stanley Smith Barney LLC.
Financial Impact
$278,400 sale of 10,000 shares by an officer
insider ownershipshare float
Risk Factors
- Potential negative perception if the sale proceeds near earnings or clinical trial readouts
- Limited float in biotech stocks can amplify price impact if multiple insiders sell concurrently
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003074 |
| Document: 0001950047-26-003074-index.html | 0001950047-26-003074 |
| Document: 0001950047-26-003074.txt | 0001950047-26-003074 |
22 reports for RAPP
67% Hit rate @ T+5 Went positive at some point 6 of 8 best @ T+60▲ +24.87%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | Insider Cluster | $26.00 | awaiting T+5 | — | $25.93 (−0.27%) |
Oct 22, 2026 4d ago | Insider Cluster | $27.33 | awaiting T+5 | — | $25.93 (−5.12%) |
Oct 21, 2026 4d ago | Insider Buy | $26.53 | awaiting T+5 | — | $25.93 (−2.26%) |
Oct 20, 2026 6d ago | 8-K | $29.37 | awaiting T+5 | — | $25.93 (−11.71%) |
Oct 6, 2026 19d ago | 144 | $30.86 $28.33 | ▲ +8.20% | ▲ +7.22% | $25.93 (+15.98%) |
Oct 1, 2026 24d ago | Insider Cluster | $32.17 $30.65 | ▼ −4.72% | ▼ −5.89% | $25.93 (−19.40%) |
Aug 26, 2026 8w ago | Insider Cluster | $50.83 $47.65 | ▼ −6.26% | ▼ −6.52% | $25.93 (−48.99%) |
Aug 5, 2026 11w ago | 8-K | $42.44 $47.73 | ▲ +12.46% | ▲ +12.11% | $25.93 (−38.90%) |
Jul 1, 2026 16w ago | Insider Cluster | $38.97 $41.75 | ▲ +7.13% | ▲ +5.77% | $25.93 (−33.46%) |
Jun 30, 2026 16w ago | 144 | $39.39 $39.72 | ▲ +0.84% | ▲ +0.58% | $25.93 (−34.17%) |
Showing 10 of 22
US Market Status
Market Closed — Opens in 2h 42m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers